Psilocybin's potential in treating methamphetamine use disorder with Jonathan Brett

In this episode, Dr Elle Wadsworth talks to Professor Jonathan Brett, a senior consultant at St. Vincent’s Hospital, Sydney, clinical director of the Psychiatry and Non-Prescription Drug and Alcohol Unit, and a clinical toxicologist with the New South Wales Poison’s Information Centre, Australia. The interview covers Jonathan’s research article looking at psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study

Psilocybin and what psilocybin-assisted psychotherapy looks like [01:20]
Why look at methamphetamine use disorder? [04:38]
Why is psilocybin promising for methamphetamine use disorder? [06:21]
Explaining the single-arm open label pilot trial [09:35]
The key findings of the study [10:54]
The efficacy of psilocybin for methamphetamine use disorder treatment [12:12]
The implications of the findings for policy and practice [14:50]
The increased interest in psychedelics and a note of caution [17:03]

About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health.

About Jonathan Brett: Jonathan is a senior consultant in clinical toxicology and addiction medicine at St. Vincent’s Hospital, Sydney, clinical director of the Psychiatry and Non-Prescription Drug and Alcohol Unit and a clinical toxicologist with the New South Wales Poison’s Information Centre. He has fellowships with the Royal Australian College of Physicians in clinical pharmacology, toxicology and addiction medicine. He is a conjoint Professor with St. Vincent’s Clinical School, University of New South Wales (UNSW) and a Senior National Health and Medical Research Council (NHMRC) Research Fellow with the Medicines Policy Unit of Centre for Big Data Research in Health, UNSW. He is president elect of the Royal Australasian College of Physicians College of Addiction Medicine. He was chief investigator on a pilot study of psilocybin facilitated psychotherapy (PP) for methamphetamine use disorder (MAUD), the first PP study of addiction in Australia and the first for MAUD worldwide. He is also chief investigator on a trial of PP for treatment resistant depression and chief medical advisor for a study of psilocybin microdosing for depression.

Original article: Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study. Doi: 10.1111/add.70187

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(136)

Chemsex trajectories among gay, bisexual and other men who have sex with men with Nikolay Lunchenkov

In this episode, Dr Elle Wadsworth talks to Dr Nikolay Lunchenkov, medical doctor, a global health specialist, and a doctoral candidate in Global Health at the Technical University of Munich, Germany....

10 Jul 21min

Drug sellers' use of drug checking services with Pablo Gonzalez Nieto

In this episode, Dr Elle Wadsworth talks to Pablo Gonzalez Nieto, a harm reduction provider, drug checking technician, and research assistant at Substance Drug Checking within the Canadian Institute f...

3 Jul 21min

How state regulations shape kratom exposure and harm with Grant Comstock and Ryan Feldman

In this episode, Dr Tsen Vei Lim talks to Drs Grant Comstock and Ryan Feldman. Grant is an Assistant Professor at the Medical College of Wisconsin and Associate Medical Director of the Wisconsin Poiso...

26 Jun 21min

Drug use related problems in Ethiopia with Tesfa Yimer

In this episode, Dr Elle Wadsworth talks to Dr Tesfa Yimer, a postdoctoral researcher at the National Centre for Youth Substance Use Research, The University of Queensland, Australia. The interview co...

19 Jun 16min

Use and harms of gamma-hydroxybutyrate (GHB) with Amy Peacock and Krista Siefried

In this episode, Dr Elle Wadsworth talks to Dr Amy Peacock, an Associate Professor and Deputy Director of the National Drug and Alcohol Research Centre, University of New South Wales, and Dr Krista Si...

12 Jun 23min

Swapping smoking for vaping in England with Vera Buss and Leonie Brose

In this episode, Annika Theodoulou speaks to Dr Vera Buss, a Senior Research Fellow at University College London, and Professor Leonie Brose, a Professor of Addictions & Public Health at King's Colleg...

5 Jun 11min

Economic effects of reducing consumption of unhealthy commodities with Damon Morris

In this episode, Dr Elle Wadsworth talks to Dr Damon Morris, a Research Fellow in the Sheffield Addictions Research Group, School of Medicine and Population Health, at the University of Sheffield, UK....

29 Mai 17min

Deceptive design features of online gambling platforms with Philip Newall

In this episode, Dr Tsen Vei Lim talks to Dr Philip Newall, a Senior Lecturer at the University of Bristol, UK. The interview covers Philip’s opinion and debate article on sludge, dark patterns and da...

22 Mai 25min